Jose “Pepe” Carmona

Chief Financial Officer

Pepe joined Rubius Therapeutics as Chief Financial Officer in September 2020. Pepe previously served as the Chief Financial Officer of Radius Health, a biopharmaceutical company developing and commercializing endocrine therapeutics. At Radius Health, he was responsible for all financial aspects of the business as well as investor relations, business development and other operational functions. Under Pepe’s leadership, Radius Health was transformed from a clinical-stage company to a fully commercial organization. Pepe was instrumental in financing the company’s commercialization and pipeline investments, executing several business development transactions and building the finance organization, processes and systems. Prior to joining Radius, Pepe was Chief Financial Officer of Innocoll Holdings PLC, acquired by Gurnet Point L.P. Previously, Pepe held numerous financial management positions with increasing responsibilities at Novartis AG, in various divisions, as chief financial officer in Europe, North America, Latin America and held other senior global financial roles.

Pepe received his B.S. in Industrial Civil Engineering from Universidad Tecnica Federico Santa Maria in Valparaiso, Chile, and his M.B.A. from Columbia Business School in New York City.